EMA grants niraparib orphan drug status for glioma
The European Medicines Agency has granted Orphan Drug Designation to niraparib for the treatment of glioma, including glioblastoma, following similar ...
The European Medicines Agency has granted Orphan Drug Designation to niraparib for the treatment of glioma, including glioblastoma, following similar ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.